In light of the ubiquitous expression of nAChRs and β-ARs in mammalian cells12–13, these findings prompted research into the potential role of neurotransmitter receptors of the nicotinic cholinergic and beta-adrenergic families in the development, progression and resistance to therapy of cancer. Here, CTBP1 is linked to cancer.